Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohort

Riordan T (2007) Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome. Clin Microbiol Rev 20(4):622–659

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henry S, DeMaria A Jr., McCabe WR (1983) Bacteremia due to Fusobacterium species. Am J Med 75(2):225–231

Article  CAS  PubMed  Google Scholar 

Citron DM (2002) Update on the taxonomy and clinical aspects of the genus fusobacterium. Clin Infect Dis 35(Suppl 1):S22–S27

Article  PubMed  Google Scholar 

Jang SS, Hirsh DC (1994) Characterization, distribution, and microbiological associations of Fusobacterium spp. in clinical specimens of animal origin. J Clin Microbiol 32(2):384–387

Article  CAS  PubMed  PubMed Central  Google Scholar 

Centor RM et al (2015) The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med 162(4):241–247

Article  PubMed  Google Scholar 

Brazier JS et al (2002) Fusobacterium necrophorum infections in England and Wales 1990–2000. J Med Microbiol 51(3):269–272

Article  CAS  PubMed  Google Scholar 

Brazier JS (2006) Human infections with Fusobacterium necrophorum. Anaerobe 12(4):165–172

Article  PubMed  Google Scholar 

Fujiwara N et al (2020) Involvement of Fusobacterium species in oral Cancer progression: a Literature Review Including other types of Cancer. Int J Mol Sci, 21(17)

Mitsuhashi K et al (2015) Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget 6(9):7209–7220

Article  PubMed  PubMed Central  Google Scholar 

McCoy AN et al (2013) Fusobacterium is associated with colorectal adenomas. PLoS ONE 8(1):e53653

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swidsinski A et al (2011) Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60(1):34–40

Article  PubMed  Google Scholar 

Strauss J et al (2011) Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 17(9):1971–1978

Article  PubMed  Google Scholar 

Leal J et al (2010) Development of a novel electronic surveillance system for monitoring of bloodstream infections. Infect Control Hosp Epidemiol 31(7):740–747

Article  PubMed  Google Scholar 

Friedman ND et al (2002) Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797

Article  PubMed  Google Scholar 

Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

Article  CAS  PubMed  Google Scholar 

Quan H et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130–1139

Article  PubMed  Google Scholar 

Queensland Population Projects (2002) to 2026. 22 September 2021]; https://public.tableau.com/views/HHSpopulationprojections

Laupland KB et al (2018) Culturing rate and the surveillance of bloodstream infections: a population-based assessment. Clin Microbiol Infect 24(8):910e1–910e4

Article  Google Scholar 

Almohaya AM et al (2020) Fusobacterium bloodstream infections: a literature review and hospital-based case series. Anaerobe 62:102165

Article  CAS  PubMed  Google Scholar 

King M et al (2020) The link between Fusobacteria and Colon cancer: a fulminant example and review of the evidence. Immune Netw 20(4):e30

Article  PubMed  PubMed Central  Google Scholar 

Alon-Maimon T, Mandelboim O, Bachrach G (2022) Fusobacterium nucleatum and cancer. Periodontol 2000 89(1):166–180

Article  PubMed  PubMed Central  Google Scholar 

Legaria MC et al (2005) Clindamycin-resistant Fusobacterium varium bacteremia and decubitus ulcer infection. J Clin Microbiol 43(8):4293–4295

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vidaurrazaga MM, McKinley GF, Camins BC (2020) Postpartum Fusobacterium gonidiaformans bacteremia. Anaerobe 62:102168

Article  PubMed  Google Scholar 

Garcia-Carretero R et al (2017) Clinical features and outcomes of Fusobacterium species infections in a ten-year follow-up. J Crit Care Med (Targu Mures) 3(4):141–147

Article  PubMed  Google Scholar 

Pett E, Saeed K, Dryden M (2014) Fusobacterium species infections: clinical spectrum and outcomes at a district general hospital. Infection 42(2):363–370

Article  CAS  PubMed  Google Scholar 

Yang CC et al (2011) Characteristics and outcomes of Fusobacterium nucleatum bacteremia–a 6-year experience at a tertiary care hospital in northern Taiwan. Diagn Microbiol Infect Dis 70(2):167–174

Article  PubMed  Google Scholar 

Yusuf E, Wybo I, Piérard D (2016) Case series of patients with Fusobacterium nucleatum bacteremia with emphasis on the presence of cancer. Anaerobe 39:1–3

Article  PubMed  Google Scholar 

Bourgault AM et al (1997) Fusobacterium bacteremia: clinical experience with 40 cases. Clin Infect Dis 25(Suppl 2):S181–S183

Article  PubMed  Google Scholar 

Afra K et al (2013) Incidence, risk factors, and outcomes of Fusobacterium species bacteremia. BMC Infect Dis 13:264

Article  PubMed  PubMed Central  Google Scholar 

Su CP et al (2009) Fusobacterium bacteremia: clinical significance and outcomes. J Microbiol Immunol Infect 42(4):336–342

PubMed  Google Scholar 

Candoni A et al (2003) Fusobacterium nucleatum: a rare cause of bacteremia in neutropenic patients with leukemia and lymphoma. Clin Microbiol Infect 9(11):1112–1115

Article  CAS  PubMed  Google Scholar 

Fanourgiakis P et al (2003) Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases. Support Care Cancer 11(5):332–335

Article  CAS  PubMed  Google Scholar 

Seibel J et al (2020) Fusobacterium nucleatum bacteremia with pneumopathy in a patient receiving eculizumab: a case report. Anaerobe 61:102099

Article  CAS  PubMed  Google Scholar 

Wolff L et al (2021) COVID-19-Associated Fusobacterium nucleatum Bacteremia, Belgium. Emerg Infect Dis 27(3):975–977

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aldridge KE et al (2001) Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother 45(4):1238–1243

Article  CAS  PubMed  PubMed Central  Google Scholar 

Könönen E et al (1999) beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. Antimicrob Agents Chemother 43(5):1270–1273

留言 (0)

沒有登入
gif